Status:
WITHDRAWN
Botulinum Toxin for Carpal Tunnel Syndrome
Lead Sponsor:
University of Minnesota
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To compare local steroid injections to local Botulinum toxin A injection in a double-blinded study.
Detailed Description
To compare local steroid injections to local Botulinum toxin A injection in a double-blinded study. The goal is to investigate if Botulinum toxin A injections are effective for Carpal Tunnel Syndrome ...
Eligibility Criteria
Inclusion
- Any individual with symptoms of carpal tunnel syndrome and a diagnosis of CTS either clinically or via EMG will be included into this study. There will be a total of 20 subjects displaying symptoms of CTS. The gender of the subjects will not determine enrollment. There is no requirement of male to female ratio for this study. There is no age cut-off or minimal age requirement to enroll in the study. No specific Racial or ethnic restrictions will be present for this study. Female subjects of childbearing potential (not surgically sterile or postmenopausal for at least 2 years) must have a negative pregnancy test at screening.
Exclusion
- Any individual who has a diagnosis of CTS (by EMG or other means) but no symptoms of CTS will be excluded from this study.
- Vulnerable subjects as defined as children, pregnant women, those with limited autonomy, decisional incapacity and prisoners will not be enrolled in this study.
- Individuals with any history of carpal tunnel release surgery and recurrent or persistent symptoms will be excluded form this study.
- Subject is pregnant or lactating.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00701233
Start Date
June 1 2012
End Date
October 1 2018
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota PM&R Department
Minneapolis, Minnesota, United States, 55455